None listed
Conditions
Brief summary
This study is designed to investigate whether the addition of an extra treatment improves low back pain, compared to standard physiotherapy treatment. The extra treatment consists of gentle manipulation of the organs of the chest, abdomen and pelvis.
Interventions
Manipulation of the thoracic, abdominal and pelvic organs and their associated supportive ligaments, connective tissue and fascia. In addition, joint manipulation, specific exercise and functional exercise prescription included in treatment. Treatments will be administered 1-2 x week for a maximum of 12 treatments over 6 weeks. Treatment sessions will last 30 mins and will be administered by an experienced physiotherapist with specialist training in joint manipulation and visceral manipulation. This frequency will be determined according to need.
Sponsors
Study design
Eligibility
Inclusion criteria
To take part in the trial, participants must meet all of the following criteria: Primary area of complain extending from the 12th rib to the buttock crease. New episode of LBP. This is defined as an episode which was preceded by a period of at least one month without LBP LBP symptoms which have a score of 3/10 or more on numerical pain rating scale
Exclusion criteria
Known or suspected serious spinal pathology Nerve root compromise evidenced by at least two of the following (i) myotomal weakness, (ii) dermatomal or widespread sensory loss, (iii) hypo or hyper-reflexia of the lower limb reflexes. Spinal surgery within the preceding six months. If currently receiving any other physical therapy for LBP If pregnant or intending to become pregnant. Currently taking medications that significantly alter gut motility Currently taking medications such as oral cortico-steroids which are known to increase the risk of intestinal perforation A known gastrointestinal disease that associates with a risk of intestinal perforation e.g. Crohn’s disease, diverticular disease, peptic ulcer disease Known to be taking anti-platelet medications such as Warfarin and Clopidogrel